leisure time -WSS

leisure time

author：leisure time 2025-09-05 09:09:54 - browse：8

Illustration of doctor with an computer text bubble for a face for a story on Chat GPT and AI – health tech coverage from STAT — Mike Reddy for STAT

Health care companies are racing to incorporate generative AI tools into their product pipelines and IT systems after the technology displayed an ability to perform many tasks faster, cheaper — and sometimes better — than humans.

But the rush to harness the power of so-called large language models, which are trained on vast troves of data, is outpacing efforts to assess their value. AI experts are still trying to understand, and explain, how and why they work better than prior systems, and what blind spots might undermine their usefulness in medicine.

It remains unclear, for example, how well these models will perform, and what privacy and ethical quandaries will arise, when they’re exposed to new types of data, such as genetic sequences, CT scans, and electronic health records. Even knowing exactly how much data must be fed into a model to achieve peak performance on a given task is still largely guesswork.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： ALS groups 'won't be played again' by the FDA, drug sponsors

explore

focus

WSS

ALS groups 'won't be played again' by the FDA, drug sponsors

Clinical trials giant ICON acquires HumanFirst

FogPharma raises $145 million in rare Series E round

First over

Florida health officials providing scant details on measles cases

IVF doctors demand details after CooperSurgical lawsuit

leisure time

leisure time

knowledge

Guidelines to prevent youth baseball injuries need more muscle

AstraZeneca loses challenge to Medicare drug price negotiation

BioMarin wins approval for gene therapy to treat hemophilia A

Clinical trials giant ICON acquires HumanFirst

Bright Health sells Medicare Advantage business to Molina

Flu vaccine offering decent levels of protection this winter, new data show

BioMarin wins approval for gene therapy to treat hemophilia A

Pfizer highlights cancer drugs it thinks could reignite investor interest

United colonoscopy coverage change 'may cost lives,' doctors say

Florida health officials providing scant details on measles cases

hotspot

A new approach to psychiatric drug development

First over

Florida health officials providing scant details on measles cases

Kenai launches with $82 million for Parkinson’s stem cell therapy

RSV vaccines may be linked to small increased risk of developing GBS

Clinical trials giant ICON acquires HumanFirst

explore

focus

focus

focus